To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
September 5, 2008
Pierre P. Massion, MD (Damon Runyon-Lilly Clinical
Investigator '03-'08) of Vanderbilt University, Nashville,
and colleagues identified a panel of genetic alterations (“genomic
signature”) that correlates with smoking history and non-small cell
lung cancer. These findings may indicate new genetic pathways involved
in lung cancer development that can be targeted for early detection and
prevention. The work was published in American Journal of Respiratory and Critical Care Medicine.
Click here for more.